Encapsulate ^Companies

Encapsulate is an organization that develops automated tumor-on-a-chip systems to screen the response profile of cancer patients to chemotherapy drugs and determine effective personalized treatment regimens. Their platform reduces unnecessary chemotherapy cycles, lowers costs and treatment duration, increases treatment success rates, and improves the patient's overall quality of life. With a comprehensive patient biobank and automation systems, Encapsulate also supports pharmaceutical companies in running pre-clinical trials, patient stratification, and deep mechanism studies. They have tested over 50 cancer drugs and can customize assays to resolve solubility, targeting, and stability issues.